(Date:11/20/2008)... FORT WORTH, Texas, Nov. 20 /PRNewswire-FirstCall/...Wound Management Technologies, Inc., (WNDM),anno...icacy of their advanced,wound care collagen produ...,November/December 2008 issue of Podiatry Managem...anagement on the Leading Edge: Case Presentations ...
(Date:11/20/2008)... NEW YORK, November 20 S...eloper of biosensor and microprocessor,technologi...ed its results,for the nine-month period ended Se...eterioration in the macro-economic environment,g...421,000; declines in sales,were mainly due to the...
(Date:11/20/2008)... CLAREMONT, Calif., Nov. 20 Keck ... second annual "Next Generation Bioscience Leaders...e Industry" (NGBL) forum will be held Jan. 19-23, ...cience companies. , , The forum is a partne...pment of business leaders in bioscience, and Smith...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 PacificGMP, th...ent and manufacturing, has entered into a cGMP,co...aceuticals, a,biopharmaceutical company developin...greement, PacificGMP will manufacture and perform ...ody for a Phase I/II clinical trial. A,stability...
Breaking Biology Technology:Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3SPO Medical Reports Nine Month Period Ending September 2008 2SPO Medical Reports Nine Month Period Ending September 2008 3KGI Announces Second Annual Executive Education Conference for Women in Life Sciences 2PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing 2...at Christopher Chitambar, a physician researcher a..., has found that a gallium compound might be an ef..., ,If the compound is found to be safe and effecti...forms of non-Hodgkin,s lymphoma that are resistant... cancer of the human lymphatic system, which is co...
...test piece of the University of Wisconsin-Milwauk...mmunity is in place. With the help of two corporat...he UWM Research Foundation, a fund-raising arm des...ation, which has been in the works for about six m...m both Wisconsin Energy Corp . and Harley-Davids...
...ertson doesn,t pretend to be a fortune teller, but...etting the standard in radiation therapy for some ...r of TomoTherapy, exudes confidence that the Hi-Ar..., will continue to be a competitive differentiator...ncremental treatments, have been delivered worldwi...
...n-based developer of predictive traffic informati...y with the help of a $1 million line of credit fro...nancial Group of Santa Clara, Calif. , , TrafficC...ort deployment of its cellular probe technology in...formation products and services in the United Stat...
Other Biology Technology:Cancer-fighting agent heads for clinical trials 2UWM launches research foundation 2TomoTherapy sees sustained market advantage 2TomoTherapy sees sustained market advantage 3TomoTherapy sees sustained market advantage 4(Date:11/19/2008)...gie Mellon University,s Robotics Institute have re....S. Department of Agriculture (USDA) to build auto...d one is for orange growers, but both are designed...ts. , The systems use sensors on autonomous robo... to gather a multitude of data about tree health a...
(Date:11/19/2008)...of Central Florida professor show early promise fo...rofessor James Turkson,s compounds disrupt the for... on mice. The compounds, S3I-201 and S3I-M2001, b... researchers have observed no negative side effect...Turkson said. "They,ve worked very well in mice, a...
(Date:11/18/2008).../ -- Orchid Cellmark Inc.,(Nasdaq: ORCH ), a le...ervices,today reported its financial results for...s were $14.9 million for the third quarter of 2008...of 2007. The decrease in total,revenues for the ...argely due,to lower revenues in the U.K. , ...
(Date:11/18/2008)...ittsburgh have developed a simple and quick method... two substances at the center of public concern ab...a fluorescent substance that glows bright green wh...e researchers report in the current online edition.... The intensity of the glow indicates the amount o...
Breaking Biology News(10 mins):Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 32 new compounds show promise for eliminating breast cancer tumors 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Orchid Cellmark Reports Third Quarter 2008 Financial Results 8Pitt researchers use fluorescence to develop method for detecting mercury in fish 2Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 1Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 2Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 3Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 4Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 5Promising Cystic Fibrosis Compound on Track for Development 17 1Promising Cystic Fibrosis Compound on Track for Development 17 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 1Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 3Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 1Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 2Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 3Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 4Request Info
384 Round Well Plate Sterile with lid; Thermo Labsystems wide range of 384-well plates is ideal for high-throughput screening and research. These allow miniaturization of assays and are suitable for
HLA-DRbeta (DA2)
BstX I from Promega
Biology Products: